The present invention relates to the combination of a DNA vaccination
strategy that makes use of a nucleic acid encoding an immunogenic
polypeptide, with a non-immunosuppressive inducer of tumor cell
differentiation and/or apoptosis or a tumor cell modifier, useful for
cancer therapy. Vaccine compositions and kits are provided, as well as
specific nucleic acid constructs that are particularly suitable for the
preparation of such compositions.